A Bengaluru-based startup NeuraSim is using advanced VR therapy to tackle amblyopia, commonly known as 'lazy eye', which affects up to 5% of the Indian population.
This VR-based therapy offers a more engaging and effective alternative to conventional patching therapy, showing significant improvements in vision within a shorter period.
NeuraSim's immersive VR simulations help rewire the brain's visual processing, allowing patients to integrate inputs from both eyes and improve vision.
The startup addresses the shortage of eye care specialists in India and provides customised VR therapy solutions for patients, validated through clinical testing.
NeuraSim's VR technology has received funding grants and recognition, attracting top eye care institutions in India like Aravind Eye Care as customers.
Offering two pricing models, NeuraSim makes its VR therapy more accessible to parents, aiming to reach a wider patient base for amblyopia treatment.
Challenges like hardware procurement and parental scepticism towards VR therapy have been overcome, with NeuraSim now focusing on expanding its offerings to other eye conditions and international markets.
The startup plans to be in 150-200 clinics by December 2025, aiming to make vision therapy more accessible and bridge the gap in healthcare access using AI, telehealth, and VR technologies.
NeuraSim's journey highlights the potential of VR-based therapy in revolutionizing eye care treatment and making it more inclusive and effective for patients.